Also trades as: 1873.HK (HKSE) · $vol 1M

$0.19

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 57 · $397.7M mcap · 1.01B float · 0.0001% daily turnover · Short 100% of daily vol

Revenue

$2.0B -7.8% ▼

5Y CAGR: +43.8%

Gross Profit

$687M -6.9% ▼

5Y CAGR: +34.6%

Operating Income

$270M +39.9% ▲

5Y CAGR: +37.8%

Net Income

$167M +244.1% ▲

5Y CAGR: -8.8%

EPS (Diluted)

$0.06 +204.9% ▲

5Y CAGR: -19.7%

EBITDA

$563M +44.1% ▲

5Y CAGR: +44.8%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$697M	$2.1B	$2.4B	$2.2B	$2.0B
YoY Growth	+115.7%	+201.9%	+13.1%	-9.4%	-7.8%
Cost of Revenue	$392M	$1.5B	$1.6B	$1.4B	$1.3B
Gross Profit	$305M	$651M	$816M	$738M	$687M
Gross Margin	43.7%	30.9%	34.3%	34.3%	34.6%
R&D Expenses	$66M	$92M	$136M	$128M	$88M
SG&A Expenses	$123M	$322M	$404M	$410M	$364M
Operating Expenses	$189M	$414M	$546M	$546M	$418M
Operating Income	$116M	$237M	$269M	$193M	$270M
Operating Margin	16.6%	11.3%	11.3%	8.9%	13.6%
Interest Expense	$62M	$183M	$185M	$177M	$54M
Income Before Tax	-$356M	$348M	-$459M	-$56M	$296M
Tax Expense	$23M	$47M	$45M	$44M	$74M
Net Income	-$387M	$288M	-$528M	-$116M	$167M
Net Margin	-55.5%	13.7%	-22.2%	-5.4%	8.4%
EPS (Diluted)	$-0.25	$0.15	$-0.28	$-0.06	$0.06
EBITDA	$164M	$370M	$436M	$391M	$563M
Shares Outstanding	1.57B	1.97B	1.92B	2.03B	2.14B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$1.3B	$1.1B	$1.0B	$982M	$1.0B	$832M	$883M	$1.0B
Cost of Revenue	$800M	$736M	$681M	$643M	$657M	$492M	$572M	$665M
Gross Profit	$471M	$406M	$332M	$339M	$348M	$339M	$311M	$342M
Gross Margin	37.0%	35.5%	32.8%	34.5%	34.7%	40.8%	35.2%	34.0%
R&D Expenses	$95M	$77M	$51M	$43M	$45M	$40M	$59M	$57M
SG&A Expenses	$212M	$204M	$214M	$175M	$195M	$183M	$176M	$173M
Operating Expenses	$782M	$295M	$265M	$218M	$240M	$224M	$235M	$230M
Operating Income	$165M	$125M	$67M	$122M	$108M	$116M	$76M	$111M
Operating Margin	13.0%	10.9%	6.6%	12.4%	10.8%	13.9%	8.6%	11.1%
Interest Expense	$0	$0	$0	$0	$11M	$9M	$19M	$15M
Income Before Tax	-$396M	$37M	-$93M	$186M	$110M	$172M	$144M	$110M
Tax Expense	$23M	$23M	$21M	$41M	$32M	$23M	$25M	$9M
Net Income	-$437M	$1M	-$117M	$117M	$50M	$122M	$96M	$80M
Net Margin	-34.4%	0.1%	-11.6%	11.9%	5.0%	14.6%	10.9%	8.0%
EPS (Diluted)	$-0.23	$0.00	$-0.05	$0.05	$0.02	$0.05	$0.10	$0.03
EBITDA	$252M	$228M	$163M	$215M	$217M	$215M	$178M	$206M
Shares Outstanding	1.92B	1.92B	2.14B	2.14B	3.59B	2.51B	950M	2.36B

VBIZF OTC